Ash 2024 Embargoed

Ash 2024 Embargoed. Upon abstract acceptance for presentation at the annual meeting, the content and conclusions of the abstract are embargoed from publication. It seems to be everywhere, shaping research and clinical practice in exciting ways.

Upon abstract acceptance for presentation at the annual meeting, the content and conclusions of the abstract are embargoed from publication. Ash will see oral presentations from two mezigdomide studies, featuring combinations with various multiple myeloma drugs.